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Pseudomonas aeruginosa (Pa) is the most common virulent pathogen contributing to the
pathogenesis of cystic ﬁbrosis (CF). During bacterial lung colonization, the products of its
metabolism are released in the extracellular space contributing to the pathogenic events associated
with its presence. To gain insights on the mechanisms involved in the Pa pathogenesis we focused
our attention on proteins released by Pa using a MudPIT approach combined with cell biology
assays. Conditioned medium collected under aerobic and microaerobic conditions from Pa clinical
strains (in early and late colonization), unlike the laboratory strain, induced expression of IL-8
mRNA in CF airway epithelial cells. We have identiﬁed proteins released by clinically relevant Pa
strains, focusing on the pro-inﬂammatory eﬀects as metalloproteases (MMPs). In fact, their
expression pattern was associated with the highest pro-inﬂammatory activity measured in the
early clinically isolated strain. The relation was further supported by the result of the analysis of a
larger and independent set of Pa isolates derived from sporadically and chronically infected CF
patients: 76% of sporadic samples expressed protease activity (n = 44), while only 27% scored
positive in the chronically infected individuals (n = 38, p o 0.0001, Fisher’s exact test). Finally,
looking for a possible mechanism of action of bacterial MMPs, we found that CM from early
clinical isolates can cleave CXCR1 on the surface of human neutrophils, suggesting a potential
role for the bacterially released MMPs in the protection of the pathogen from the host’s response.
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Insight, innovation, integration
We applied a recently developed shotgun proteomic approach
(MudPIT) to protein-free conditioned medium (CM) obtained
from a laboratory and two P. aeruginosa clinical strains to
identify candidate molecules involved in P. aeruginosa viru-
lence under comparable in vivo conditions. In our work we
describe for the ﬁrst time the eﬀect of oxygen limitation on
the proﬁle of polypeptides released by laboratory and clinical
isolates of P. aeruginosa. Bacterial MMPs were identiﬁed as
putative biomarkers associated to Pa pro-inﬂammatory
activity, and their activity was conﬁrmed to be present in
majority of sporadic strains isolated from diﬀerent patients.
This integrated approach is capable of providing quantitative
and qualitative data that link the biology of P. aeruginosa
strains to CF lung disease through the identiﬁcation of released
polypeptides capable of modulating host’s response to this
important pathogen.
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Introduction
Pseudomonas aeruginosa (Pa) is a common Gram-negative
bacterium noted for becoming resistant to antibiotics and
for causing opportunistic infections, ranging from acute, as
in immunocompromised patients, to chronic, as in patients
aﬀected by cystic ﬁbrosis (CF).1 Pa chronic airway infection is
the main cause of morbidity and mortality in CF patients.2,3
CF lung disease is characterized by transient airway Pa
infection and excessive neutrophils-dominated inﬂammation
early in life followed by permanent chronic infection that
causes persistent respiratory symptoms and decline in lung
function.4 Persistence of Pa in the CF airways involves several
genotypic and phenotypic changes of bacterium ranging from
loss of ﬂagellar-dependent motility or antibiotic resistance to
increased alginate production and occurrence of mucoid
variants.5–8
In CF airways, bacteria may encounter a low-oxygen
environment developed during infection or as a consequence
of bioﬁlm creation.6,9 Under these conditions Pa strains often
grow within the mucus plugs without direct contact with
epithelium and they can utilize alternative external electron
acceptors such as nitrate, nitrite or nitrous oxide that are
present at high levels in CF airway mucus.6 However, the
products of their metabolism are released in the extracellular
space contributing to the pathogenic events associated with
the presence of Pa.10
In the present study we have evaluated the pro-inﬂammatory
properties of the ultra-ﬁltered (30 kDa) conditioned medium
(CM), obtained from laboratory and clinical Pa strains
grown under both aerobic and microaerobic conditions, on
CF bronchial epithelial cells.
Several studies focusing on the Pa colonization in CF lung
have been performed at the transcriptome level.11–13 In contrast,
a few works have been dedicated to proteomic analysis.13–16 The
identiﬁcation of proteins that change their expression among
clonal P. aeruginosa morphotypes represents a crucial aspect to
understand which molecules are involved in Pa microevolution,
as well as in the intrinsic adaptation ability of Pa. Therefore we
investigated the polypeptides released by the laboratory strain
PAO1 and clinical isolates cultured in both aerobiosis and
microaerobiosis. By means of a semi-quantitative label-free
approach17 various sets of diﬀerentially represented proteins
were obtained and some of them were conﬁrmed by orthogonal
methods, such as Western blot and zymography assay. In
particular our attention focused on the expression and activity
of some metalloproteases (MMPs) which were further assayed in
a larger set (n = 82) of clinical isolated strains from various
patients featuring sporadic or chronic colonization.18 Finally it
has been tested whether the bacterial MMPs could cleave the
chemokine receptor CXCR1 on the surface of freshly isolated
peripheral blood neutrophils (PMNs), a feature associated with
the disabling of their bacterial killing capacity.19
Results
In this work we aimed to identify the bacterial proteins
released by laboratory (PAO1) and Pa clinical strains, deﬁned
as early (AA2), and late (AA43) isolates.20 to characterize
candidate pro-inﬂammatory mediators, occurring during
acute and/or chronic colonization. In addition the eﬀect of
oxygen limitation on the protein level of the Pa clinical strains,
comparing their adaptation to microaerobiosis to that of
PAO1, has been evaluated.
Eﬀects of Pa conditioned medium on IL-8 mRNA expression in
a CF airway epithelial cell line
Looking for potential virulence factors contributing to the typical
inﬂammatory response, the induction of a pro-inﬂammatory
marker (IL-8) expressed by a CF epithelial airway cell line
(16HBE 14o- AS3) in response to 30 kDa cut-oﬀ ultra-ﬁltered
CM derived from Pa strains was measured. Following exposure
to CM from AA2 grown under both aerobic and microaerobic
conditions, the IL-8 mRNA expression was induced approxi-
mately 5 and 4 times, respectively (Fig. 1). When 16HBE
14o- AS3 cells were exposed to CM of AA43 the IL-8 mRNA
expression increased about 4 and 2.5 times, in aerobiosis and
microaerobiosis, respectively. In contrast, the exposure of CF
cells to CM derived from the laboratory strain PAO1 did not
induce statistically signiﬁcant regulation.
To evaluate whether polypeptides were involved in regula-
tion of IL8 expression, we incubated CM from AA2 overnight
at 37 1C in the presence or absence of trypsin. Loss of
metalloprotease activity under both experimental conditions
was detected and was followed by a decreased expression of
IL-8 mRNA of about 60% by the CF epithelial cells treated
with CM from AA2 incubated at 37 1C (data not shown).
Identiﬁcation of released proteins by Pa laboratory and clinical
strains
Replicate MudPIT analyses (n = 7) of CM from laboratory
and clinical strains permitted the identiﬁcation of 363 distinct
proteins, about 50% of them identiﬁed at least by 2 diﬀerent
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Fig. 1 IL-8 mRNA expression. Relative expression of IL-8 mRNA
based on real-time PCR analysis of 16HBE 14o-AS3 cells exposed to
10% of CM of PAO1, AA2 and AA43 grown under aerobic and
microaerobic conditions (means +/ SD) (n= 5; **po 0.01, ***po
0.001). CTRL, corresponding to the basal IL-8 mRNA expression of
16HBE 14o-AS3 cells exposed to 10% MVBM alone, was set to 1.
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peptides (see ESIw—Table S1). Speciﬁcally, 157, 304 and 88
total proteins were characterized from CM of PAO1, AA2 and
AA43, respectively (Fig. 2). Using MAProMa software each
sample list was plotted on a 2D map, using theoretical MW
and pI of identiﬁed proteins. As an example, Fig. S1 (see ESIw)
shows a typical 2D map obtained for AA2 strain. The protein
lists corresponding to the diﬀerent conditions and strains (see
ESIw—Table S1) were processed by unsupervised hierarchical
clustering indicating a grouping aﬀected more by strain type
than by culture conditions (+/ O2). In addition, isolated late
strain (AA43) grouped closer to the laboratory one (PAO1)
than to the early isolated strain (AA2) (Fig. 3).
Diﬀerential analysis between the diﬀerent Pa strains and oxygen
conditions
In previous works the correlation between Score or Spectral
Count values, obtained from the SEQUEST algorithm, and
the relative amount of the proteins was demonstrated.21,22
In this context, using the DAve and DCI algorithms17 of
MAProMa software and taking into account the hierarchical
clustering results, the relative protein abundance by means of
a label-free quantitative approach was evaluated. In this way,
18 proteins showed diﬀerential regulation upon comparing
PAO1 and AA2 grown under aerobic conditions: 12 proteins
were up- and 6 down-regulated in the CM of the clinical strain
(Fig. 4A). While 22 proteins resulted to be diﬀerentially
regulated upon comparing PAO1 and AA2 grown under
microaerobic conditions (Fig. 4B). Some of these proteins
presented the same trend comparing laboratory and early
isolated strains regardless of the growth conditions. Speciﬁcally,
ﬂagellar capping protein FliD (GI 15596291) and ﬂagellin type B
(GI 15596289) were found up-regulated in the laboratory strain
PAO1; while exoenzyme S (GI 15599036) and molecular chaper-
one DnaK (GI 15599955) showed up-regulation in the early
isolated clinical strain AA2.
The role of oxygen limitation, a condition associated with
acute and chronic ﬂogosis and/or as a consequence of bioﬁlm
creation,6,9 was also evaluated by comparing the proteins
released by each strain grown under aerobic and microaerobic
conditions. Of note, a probable binding protein component of
ABC (GI 15597400) presented a similar regulation from
aerobiosis to microaerobiosis for both laboratory and clinical
strains (see ESIw—Fig. S2).
To gain more insights on the role of candidate virulence
factors and at the same time to further validate our approach,
two pro-inﬂammatory candidates, the exoenzyme S and the
alkaline metalloprotease AprA, characterized by up-regulation
in the AA2 CM compared to the PAO1 one, were selected
(Fig. 4). On the other hand, alkaline metalloprotease AprA and
exoenzyme S resulted to be up- and down-regulated, respec-
tively, when AA2 strain was grown under aerobic conditions
(see ESIw—Fig. S2).
Western blot analysis conﬁrmed that, in aerobiosis,
exoenzyme S was undetectable in PAO1 but it was present
in AA2 strain. In microaerobiosis, it was identiﬁed in the
PAO1 strain and found up-regulated in AA2; while it was
undetectable in AA43 CM (Fig. 5, lane A). Concerning alka-
line metalloprotease AprA, functional assay (zymography)
and Western blot analysis conﬁrmed that this protein was
more expressed in AA2 strain (speciﬁcally up-regulated in
aerobiosis). In contrast, its level in PAO1, like in AA43, was
undetectable in microaerobiosis and moderately increased
under aerobiosis conditions (Fig. 5, lanes B and C).
Metalloprotease activity in a large set of sporadic and chronic
isolated clinical Pa strains
Several proteases, including metalloproteases (MMPs), were
identiﬁed by the MudPIT analyses. Using high stringency
thresholds for DAve and DCI algorithms (0, 4 and 400,
respectively), only AprA showed diﬀerential regulation.
However, other proteases presented a similar behaviour;
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Fig. 2 Venn diagram of the proteins identiﬁed by MudPIT experi-
ments. Distribution of the total proteins identiﬁed in the CMs of
PAO1, AA2 and AA43 grown under aerobic and microaerobic con-
ditions (B).
Fig. 3 Unsupervised hierarchical clustering of protein lists identiﬁed in
CM of PAO1, AA2 and AA43 grown under aerobic and microaerobic
conditions. Clustering was performed usingWard method distance47 and
the SEQUEST Score values of the proteins identiﬁed with high conﬁdence
for each analyzed experimental condition (see ESIw—Table S1).
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in particular, their abundance increased under aerobic conditions
(see ESIw—Table S2). Of note, a protease inhibitor, the ecotin
(GI 15597951), was readily identiﬁed to be up-regulated in the
CM of PAO1 (Fig. 4B and ESIw—Table S2).
For evaluating the impact of the MMPs, their activity and
the speciﬁc expression of AprA were assayed in a large set of
clinical strains isolated from two groups of CF patients
selected on the basis of the type of colonization (n = 82). In
particular, MMP activity was detected in 76% (29 of 38) and
27% (12 of 44) of sporadic and chronic strains, respectively
(po 0.0001, Fisher’s exact test; see ESIw—Tables S3 and S4).
In order to evaluate whether the MMP activity detected was
associated with alkaline metalloprotease AprA, we investi-
gated the presence of this protein in a subset of both chronic
and sporadic strains selected for a positive MMP activity. As
AprA was not detected in all of the strains positive for MMP
activity, the presence of other gelatinases is the most likely
explanation (Fig. 6A and B). These ﬁndings conﬁrm the
MudPIT data concerning the presence in CM of other pro-
teases (see ESIw—Table S2).
Metalloproteases cleave CXCR1 on the surface of neutrophils
(PMNs)
In CF individuals it has been reported that neutrophil-derived
proteases could mediate the cleavage of CXCR1 on their
surface, thus disabling their bacterial-killing capacity.19 To
test whether also Pa-derived proteases could contribute to
cleave CXCR1, peripheral blood neutrophils puriﬁed from
healthy donors were treated for 2 hours at 37 1C with CM
obtained from laboratory (PAO1) and clinical strains
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Fig. 4 Diﬀerentially regulated proteins identiﬁed in PAO1 versus AA2, under aerobic (A) and microaerobic conditions (B). Positive DAve values
(black bars) correspond to up-regulation in PAO1 versus AA2, negative DAve values (grey bars) indicate down-regulation in PAO1 versus AA2.
Fig. 5 Target validation. Western blotting analysis of exoenzyme S in
CM of PAO1, AA2 and AA43 strains grown in microaerobiosis in
comparison to aerobiosis (lane A). Zymography assay (lane B) and
Western blot analysis (lane C) of alkaline metalloproteinase AprA in
CM of PAO1, AA2 and AA43 strains grown in microaerobiosis in
comparison to aerobiosis. Coomassie stain of the CM utilized for the
assay is shown.
Fig. 6 Target validation in a large set of clinical isolated Pa strains.
Zymography and Western blot analysis of alkaline metalloproteinase
AprA in CM of clinical isolated Pa chronic (A) and sporadic (B) strains.
Pa strains were isolated from patients identiﬁed as chronically and
sporadically infected (see methods for description of clinical criteria).
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Fig. 7 Flow cytometric analysis of CXCR1 expression on peripheral blood neutrophils (PMNs). Puriﬁed peripheral blood PMNs, isolated from
the buﬀy coat of healthy donors, were incubated for 2 hours at 37 1C in media alone (A–B) or with 10% of CM 5X from PAO1 (C–D), AA2 (E–F)
and AA43 (G–H) cultured under aerobic conditions. Cells were labeled with an Alexa Fluors 647 anti-human CXCR1 to visualize cell surface
receptors and an antibody isotype IgG1 control. Data are represented as dot plots with the x-axis indicating Forward Light Scatter and the y-axis
indicating CXCR1 ﬂuorescence intensity measured on a log10 scale.
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(AA2 and AA43) grown under aerobic conditions. A strong
decrease of CXCR1 expression (80% reduction of MFI) followed
the treatment with CM derived from AA2 clinical strain (Fig. 7).
In contrast, CXCR1 surface expression on PMNs incubated with
PAO1 and AA43 CM was almost unaﬀected, in line with the
reduced MMP activity detected in these strains.
Discussion
Inﬂammation in cystic ﬁbrosis is a hallmark of the disease
and the causative event associated with the negative outcome
of the patients who almost invariably suﬀer and eventually
die, if not subjected to organ transplantation, because of
inﬂammation-driven chronic pulmonary insuﬃciency. The
expression of the cytokine IL-8 in human bronchial epithelial
cells exposed to CM derived from Pa strains indicated that
clinical strains isolated during the early phase of lung coloni-
zation (AA2) had a pro-inﬂammatory capability higher than
induced by the Pa strain isolated during chronic colonization
(AA43) (Fig. 1).
30 kDa cut-oﬀ ultra-ﬁltered CM and the observed decrease
of inﬂammation, after incubation at 37 1C (see the Results
section), suggest that the pro-inﬂammatory eﬀect is for a
major part associated to proteins. In this context it is inter-
esting to note that AA2 released more or less twice as many
proteins as PAO1 and AA43 (Fig. 2). The use of CM obtained
from cells grown at the same optical density, during the
exponential growing phase, and the correlation with the
same number of colony-forming units per millilitre (see the
Materials and Methods section) excluded the possibility that
the diﬀerential protein expression was due to a diﬀerent degree
of cell lysis/death.23 Furthermore, these ﬁndings are in agree-
ment with those reported by Wehmho¨ner and colleagues who
investigated on Pa released proteins, by means of 2-D gel
electrophoresis, reporting the interclonal and intraclonal
diversity of the secretomes of cultured P. aeruginosa.14 The
hypermutability of the early isolated clinical strains is used to
perform a more complex protein synthesis program necessary
for their adaptation to the airways of CF patients.24 However,
Pa strains isolated during chronic colonization decrease their
pathogenicity in order to survive and successfully colonize the
host.25 In fact, unsupervised cluster analysis of the identiﬁed
protein proﬁles indicates that chronic strain (AA43) grouped
closer to PAO1 than to the sporadic one (AA2). In this
context, the comparison between laboratory and sporadic
strains evidenced 34 total proteins to be diﬀerentially ex-
pressed (Fig. 4). In particular, our data concerning two of
these proteins, exoenzyme S (GI 15599036) and alkaline
metalloproteinase AprA (GI 15596446), are conﬁrmed also
by literature data and represent interesting candidates to act as
pro-inﬂammatory molecules.15,26
Another polypeptide identiﬁed in our analysis is exoenzyme
S, a virulence factor delivered to target cells by means of a type
III contact-dependent mechanism or acting as a soluble extra-
cellular factor. It causes cytotoxicity by inducing apoptosis of
T cells as well as activating monocytes which lead to the
production of pro-inﬂammatory cytokines and chemokines.27
In addition, an interaction between its C-terminal domain and
14-3-3 proteins of eukaryotic cells has been reported.28,29
In our MudPIT analyses, exoenzyme S was detected in
PAO1 and, at higher levels in AA2 strain grown under micro-
aerobiosis. However, aerobiosis induced a down-regulation of
the protein level, a result in contrast with the increased expression
of IL-8 measured in epithelial cells (Fig. 1 and 5, lane A).
Concerning the alkaline metalloproteinase AprA, MudPIT data
indicating its up-regulation in sporadic strain and aerobiosis
conditions were conﬁrmed by zymography and Western blot
analysis. These ﬁndings suggested that the proteolytic activity
was mainly due to AprA and it was seen to be associated with the
IL-8 expression level (Fig. 1 and 5). Although the laboratory
strain PAO1 expresses detectable amounts of AprA the lower
induction of pro-inﬂammatory IL-8 mRNA expression by the
PAO1 CM could be explained by the presence of high levels of
ecotin (Fig. 4B and ESIw—Table S2), a dimeric periplasmic
protein acting as a potent inhibitor of many trypsin-like serine
proteases.30
The investigation of 82 CF patients, characterized by
detailed genetic and clinical records (see ESIw—Tables S3
and S4), shows the high percentage of correlation among
sporadic Pa infection andMMP activity, although the anti-AprA
antisera did not react with all the samples showing proteolytic
activity. This observation is consistent with the heterogeneity
of MMPs responsible for proteolytic activity and is in keeping
with the reported variability of Pa secretomes.14 Moreover, it
suggests that the relative amount of MMPs, as well as their
inhibitors, must be taken into account when the biological
eﬀects of the CM are evaluated. In fact, other proteases were
identiﬁed in the sporadic strain CM grown under aerobic
conditions (see ESIw—Table S2). Some of these proteins, such
as LasA protease, elastase LasB and Protease IV, have been
previously described as released, playing an important role in
the pathogenesis of Pa infection through the activation of
protease-activated receptor 2 (PAR-2), modulating host
inﬂammatory and immune response.31 They are known for
their strong proteolytic activities responsible for the rupture of
the tight-junction of epithelium leading to tissue invasion and
spreading of bacteria.32 In addition, also aprX (synonym of
PA1245) and aprE were found to be speciﬁcally identiﬁed in AA2
grown under aerobic conditions (Fig. 4A and ESIw—Table S1);
their genes belong to the same transcriptional unit and they are
implicated in the secretion of alkaline protease.33
The identiﬁed proteases could contribute to the degradation
of biologically active proteins involved in host inﬂammation, as
it has been reported in Serratia marcescens and P. aeruginosa
where MMPs mimic the action of the endogenous shedding
proteinase.34 Recently, studies have implicated the activity of
free airway elastase in the cleavage of CXCR1 in the airways of
CF individuals.19 In the same way, other studies showed that
the proteolytic loss of CD35 (complement receptor-1) on
neutrophils impaired the opsonophagocytosis and killing of
P. aeruginosa in cystic ﬁbrosis lung disease.35,36 The selective
cleavage of CXCR1 by the CM from AA2 strain indicates that
microbial proteases may likely be involved in the modiﬁcation
of phagocytes’ activity within the host organism. It is possible to
speculate that the eﬀect of released MMPs could be more
relevant in the early phases of infection, when neutrophils
encounter for the ﬁrst time the microorganism and the need
to reduce cell aggressiveness toward the microorganism is
1
5
10
15
20
25
30
35
40
45
50
55
1
5
10
15
20
25
30
35
40
45
50
55
6 | Integr. Biol., 2012, ]]], 1–10 This journal is c The Royal Society of Chemistry 2012
critical for its survival. Later, when inﬂammatory cells become
predominant over bacteria the infection becomes chronic and
bacteria switch to a less virulent phenotype.
Hierarchical clustering indicates a major diﬀerence in protein
proﬁles due mainly to the strain type than the oxygen concen-
tration. On the other hand, IL-8 mRNA relative expression
shows a strong induction of the pro-inﬂammatory activity by
clinical strains (AA2 and AA43) in comparison to the laboratory
one (Fig. 1). The hypothetical protein PA3313, an outer
membrane-bound periplasmic space protein, involved in phos-
phate transmembrane transporter activity was the only protein
found increased following the shift from microaerobiosis to
aerobiosis in AA2 and AA43 strains, while it was unchanged
in PAO1. Its role as a putative Pa virulence factor deserves
additional investigations.
Conclusion
The diﬀerential patterns of proteins released by clinical and
laboratory strains represent an eﬀective strategy to dissect the
role and synergy of these proteins in the pathogenesis of CF lung
disease. Bacterial MMPs were identiﬁed as putative biomarkers
associated to Pa pro-inﬂammatory activity, and their activity was
conﬁrmed to be present in majority of sporadic strains isolated
from diﬀerent patients. MMP activity and Pa virulence appear
related, an observation further supported by the functional eﬀect,
like the CXCR1 cleavage on the surface of neutrophils we have
reported. Future evaluation of MMP activity in an even larger
series of clinical isolates collected for speciﬁc clinical parameters
will provide more insights on the correlation with lung function in
patients colonized by Pa strains. In addition, the investigation of
the complex mechanisms of Pa adaptation to the microaerobic
environment of CF lung will help in elucidating the pathogenesis
of chronic infection, as well as in ﬁnding eﬀective anti-bacterial
drugs targeting molecules responsible for the lung colonization. In
this context, the MudPIT proteomic methodology coupled to a
protein interaction network-based approach will be a powerful
strategy to investigate the biological pathways involved in patho-
genesis and adaptation of P. aeruginosa in CF patients and to
identify clinically relevant targets.
Experimental
Materials and methods
Collection of bacterial conditioned medium. P. aeruginosa
PAO1 laboratory strain and two sequential P. aeruginosa
isolates from a CF patient were chosen from the strains
collection of the Cystic Fibrosis (CF) clinic in Hannover
(kindly provided by B. Tummler, Medizinische Hochschule,
Hannover, Germany). P. aeruginosa strain AA2 was collected
at the onset of chronic colonization from the second positive
culture and it was indicated as early isolate while the strain
AA43 was deﬁned as late and it was collected 7.5 years after
colonization. Each strain was inoculated onto Difco TM
Tryptic Soy Agar (TSA: Becton, Dickinson and Company,
Le Pont de Claix, France) plates and allowed to grow at 37 1C
overnight. They were then inoculated into modiﬁed Vogel-
Bonner medium (MVBM)37 and incubated overnight with
continuous agitation. The day after, Pa cells were diluted in
MVBM to the concentration of 1  108 cfu ml1 (OD of 0.1 at
600 nm). The cultures were incubated at 37 1C for 16 hours
with continuous agitation in aerobiosis while anaerobiosis
condition was established using an anaerobic jar by adding a
sachet containing ascorbic acid as active component (Oxoid,
Basingstoke, UK).
By adding MVBM the cultures were normalized to an
optical density of 0.2 OD at 600 nm. Their conditioned
medium (CM) was collected by centrifugation (7000  g,
30 min, 4 1C) and ﬁltered through a 0.22 mm ﬁlter to remove
any remaining bacteria. Afterwards they were concentrated
about 17-fold through centrifugation (800  g, 10 min, 25 1C)
with Amicons Ultra-15 30K NMWL centrifugal ﬁlter devices
(Millipore Corporation, Bedford, MA, USA) and precoated
with 10mg ml1 bovine serum albumin (BSA, Sigma-Aldrich).
Finally, the samples were ultra-centrifuged at 70 000  g
for 1 h at 4 1C and each CM was subjected to gel ﬁltration
by means of PD-10 Desalting Columns (GE Healthcare
Bio-Sciences AB, Uppsala, Sweden) followed by ﬁltration
through a 0.22 mm ﬁlter and stored at 80 1C.
Pa strains isolated from a total of 82 CF patients featuring
sporadic or chronic colonization, followed up at the Cystic
Fibrosis Center of Verona, were also cultured. Chronic
colonization was deﬁned as the isolation of at least 3 isolates
within 6 months (minimum 30 days interval) while sporadic
colonization referred to the isolation of Pa in the bronchial
tree in the presence or absence of direct or indirect signs
of inﬂammation.38 This study was conducted according to
the principles expressed in the Declaration of Helsinki.
The Institutional Review Board of Azienda Ospedaliera
Universitaria Integrata di Verona approved the study as
project 1612. All patients provided written informed consent
for the collection of samples and subsequent analysis. The day
after inoculation onto TSA plates, these Pa clinical isolates
were treated exactly as described with the exception of con-
centration step.
Epithelial cell cultures. An epithelial respiratory cell line
(16HBE14o- AS3) with CF phenotype, lacking CFTR expression
following transfection with an antisense CFTR sequence
phenotype (a kind gift from P. Davis, Case Western Reserve
University, Cleveland, OH, USA),39 was grown in Eagle’s
MEM (Cambrex Bio Science, Verviers, Belgium) supplemented
with 10% fetal bovine serum (FBS) (Cambrex Bio Science), 1%
L-glutamine (Cambrex Bio Science) and 0.4% G418 sulfate
(Calbiochem, CN biosciences, La Jolla, CA, USA).
The cell line was cultured at 37 1C in a humidiﬁed atmo-
sphere with 5% CO2. Cells were seeded in a concentration of
4.5  105 cells cm2 and, after 24 hours, were exposed for
4 hours to 10% of CM derived from clinical and the laboratory
Pa strains. Under these conditions, as determined by the Tripan
Blue exclusion test, the cell viability was >95%.
Protease digestion of conditioned medium. The CM derived
from the sporadic strain (AA2) grown in aerobiosis was incubated
at 37 1C overnight with and without trypsin (Sigma-Aldrich) of
concentrations ranging from 200 ng ml1 to 3.125 ng ml1. It was
then treated, for 1 hour at room temperature, with 250 mM of
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trypsin inhibitor from Glycine max (Sigma-Aldrich Inc.,
St Louis, MO, USA). Finally, it was subjected to a
gelatin/zymography assay to evaluate the extent of protease
activity and select the appropriate concentration of trypsin
(25 ng ml1) to degrade the polypeptides in AA2 CM.
RNA isolation, reverse transcription and quantiﬁcation. The
16HBE14o- AS3 cells were lysed. Total RNA was extracted
with the Total RNA Isolation kit (Roche, Germany) and
converted to cDNA using the High Capacity cDNA
Archive Kit (Applied Biosystems, USA). The reaction was
then incubated at 25 1C for 10 min and at 37 1C for 2 hours.
Relative quantiﬁcation of gene expression was performed by
real-time quantitative PCR analysis as previously described.40
Results were expressed as mean  standard deviation (SD).
Proteomics analysis. A total of 200 mL of each CM sample
was concentrated to 20 mL and brought to pH 7.9 by the
addition of ammonium bicarbonate, obtaining a protein
concentration of about 1 mg mL1. One mg aliquot of sequencing
grade modiﬁed trypsin (Promega Inc., Madison, WI, USA) was
added and the formic acid (Sigma-Aldrich Inc., St Louis, MO,
USA) and the sample were desalted and concentrated using
PepClean C-18 Spin Columns (PIERCE Biotechnology Inc.,
Rockford, IL, USA). The eluent was dried in a vacuum system
and reconstituted in 5% acetonitrile, 0.1% formic acid.
Trypsin-digested samples were analyzed by two dimensional
micro-chromatography coupled to ion trap mass spectrometry
(2DC-MS/MS, also referred to as Multidimensional Protein
Identiﬁcation Technology, MudPIT),41 by Thermo Electron
Corporation (San Jose´, CA, USA). To identify the maximum
number of proteins and to verify the reproducibility of our
approach multiple biological and technical replicate analyses,
per condition, were performed (n = 7).
Brieﬂy, 10 ml of the digested peptide mixture was loaded
onto a strong cation exchange column (Biobasic-SCX column,
0.32 i.d. 100 mm, 5 mm, Thermo Electron Corporation,
Bellefonte, PA, USA), eluted stepwise with salt injections of
increasing molarity (0, 20, 40, 80, 120, 200, 400, 600, 700 mM)
and then captured in turn onto two peptide traps (Zorbax 300
SB-C18, 0.3 i.d.  5 mm, 5 mm, Agilent Technologies, Palo
Alto, CA) for concentration and desalting prior to separation
on a reversed-phase C18 column (Biobasic-18, 0.180 i.d.
100 mm, 5 mm, Thermo Electron Corporation). Additional
chromatographic and mass spectrometry details are reported
by De Palma et al.41
The experimental mass spectra produced by MudPIT analyses
were correlated to in silico peptide sequences of P. aeruginosa
protein database (5561 entries) retrieved from NCBI in 2010
(http://www.ncbi.nlm.nih.gov/); data processing was performed
by means of Bioworks 3.3.1, based on the SEQUEST algo-
rithm.42 The validity of peptide/spectrum matches was assessed
using SEQUEST deﬁned parameter thresholds. Speciﬁcally,
matching between spectra was only retained if they had a
minimum Xcorr of 1.5 for +1, 2.0 for +2 and 2.5 for +3
charge state. In addition, the thresholds of peptide/protein
probability were determined to be r103 while the protein
consensus score value Z10.43 The percentage of the false
positives identiﬁcation was estimated processing the raw mass
spectra by means of the reverse database of P. aeruginosa and the
procedure revealed a false positives rate less than 5% (data not
shown).44
Protein lists were compared and the diﬀerential expression
evaluation was performed by the MAProMA software as
previously reported.21,22 Unsupervised cluster analysis45 was
performed using a free of charge software such as Rapid
Miner (http://rapid-i.com/). In addition, in-house R-scripts,
based on XlsReadWrite, clue, clValid library, were employed
(http://cran.r-project.org).
Gelatin/zymography for metalloprotease activity. The CM
samples were treated as follows: 5 ml of 5X SDS sample buﬀer
(5% SDS, 0.5 M Tris-HCl pH 6.8, 25% glycerol) were added
to 20 ml of CM. The sample was run on a SDS-PAGE gel
containing 1 mg ml1 gelatin (Sigma-Aldrich). The gel was
washed twice (20 min per cycle) with 2.5% Triton X-100 at
room temperature, then incubated in 200 ml of activation
buﬀer (10 mM Tris-HCl, 1.25% Triton X-100, 5 mM CaCl2,
1 mM ZnCl2) overnight at 37 1C and ﬁnally stained with
Coomassie Brilliant Blue G-250 in 20% methanol/10% phos-
phoric acid/10% ammonium sulfate and destained in water.
Western blot analysis of exoenzyme S and alkaline metallo-
protease AprA. Proteins were precipitated from 12 ml of CM
by drop-wise addition of 10% (ﬁnal concentration) trichloro-
acetic acid with stirring at 4 1C. The sample was then
centrifuged at 3000  g for 30 min and washed 3 times with
an excess of an acetone : methanol (8 : 1) mixture. The pellet
was air-dried, resuspended in SDS sample buﬀer and subjected
to SDS-PAGE and Western blotting. The sample proteins
(20 ml per lane) were electrophoresed on SDS-PAGE using
10% acrylamide gel and transferred onto a nitrocellulose
membrane (HybondTM ECLTM, Amersham, NJ, USA),
using a mini trans-blot apparatus (Bio-Rad, California,
USA) following the manufacturer’s instructions. To verify
equal loading, proteins were separated in 10% polyacrylamide
gel containing SDS and stained with Coomassie Brilliant Blue
G-250 in 20% methanol/10% phosphoric acid/10% ammonium
sulfate, destained in water and examined for staining intensity.
Non-speciﬁc binding on the membrane was blocked with 5% dry
non-fat milk or 5% bovine serum albumin (BSA, Sigma-Aldrich)
in TBS-T buﬀer (0.2% Tween 20 in Tris-buﬀered saline, pH 7.5)
for 1 h at room temperature. The membrane was incubated with
a 1 : 1000 dilution of chicken polyclonal antibody raised against
exoenzyme S (Abcam plc. Cambridge, UK) or with a 1 : 500
dilution of puriﬁed rabbit IgG against alkaline metalloprotease
AprA,18 in TBS-T with 1% BSA overnight at 4 1C. The blot was
washed four times in TBS-T and then incubated for 1 h at room
temperature with a goat anti-chicken IgG secondary antibody
conjugated to biotin (SouthernBiotech, Birmingham, AL, USA)
diluted 1 : 25000 or a donkey anti-rabbit IgG secondary anti-
body conjugated to horseradish peroxidase (Amersham, NJ,
USA) diluted 1 : 15000 in TBS-T with 1% BSA. After washing
bound HRP was detected using the ECL detection system
(Millipore Corporation, Bedford, MA, USA).
Flow cytometry analysis of conditioned medium-treated neutro-
phils. Peripheral blood neutrophils (PMNs) were puriﬁed from
the buﬀy coat of healthy donors as previously described.46
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After dextran sedimentation (Destran T500, Pharmacia, Uppsala,
Sweden) and hypotonic lysis of contaminating erythrocytes, the
PMN pellet was washed in PBS counted and resuspended in
Hank’s balanced salt solution (HBSS) with 5 mMCaCl2 and 1 mM
ZnCl2 (Gibco Laboratories). The neutrophils were incubated at
37 1C for 2 hours with 10% of CM 5X from clinical (AA2 and
AA43) and laboratory (PAO1) strains grown in aerobiosis. Fresh
and ﬁxed neutrophils underwent 15 min Fc blocking. They
were then incubated with an Alexa Fluors 647 anti-human
CD 181 (CXCR1) antibody (BioLegend, San Diego, CA,
USA) for 15 min at room temperature, washed three times
with PBS and ﬁnally analyzed by four-color ﬂow cytometry
(FACSCalibur, Becton-Dickinson); twenty thousand neutrophils
were analyzed per sample. Gating of neutrophils was based on
light scatter properties and positive expression for CD45, CD16
and CD15. Data treatment and analysis was performed with Cell
Quest analysis software (Becton-Dickinson).
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